Two isogenic HCT116 colorectal cancer cell lines without (p53−/−) or with (p53+/+) normal p53 expression were used to compare the effects of monotherapy with those of simultaneous or sequential combination therapy. The gene discussed is TP53; the disease is colorectal cancer.